Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BNY enters its October 15 earnings release carrying a 13% monthly price decline, elevated options defensiveness, and a fresh cluster of analyst target cuts, making this one of the more charged setups the custody bank has seen this year.
The options market is the clearest expression of that caution. The put/call ratio has been running persistently above 1.75 for the past two weeks, near its 52-week high of 1.89. The current reading of 1.77 is broadly in line with its 20-day average of 1.74, so hedging demand has not spiked this week so much as it has stayed elevated throughout the September drawdown. That is a different pattern from a single panic bid for puts: it suggests a structural overhang of defensive positioning rather than a fresh, event-driven flush.
Short interest is not the story here. At 1.5% of free float, it remains low. The absolute share count has ticked up roughly 13% over the past month, but the level is too modest to constitute meaningful squeeze risk or to signal any coordinated short thesis. Borrow is cheap at 0.53%, and availability is essentially unconstrained, with hundreds of millions of shares available to lend. Bears who want to be short BNY face no friction whatsoever in the lending market. That they have not built a larger position despite the 13% drawdown suggests the slide is being driven by holders reducing exposure, not new shorts pressing in.
The Street's activity this week underscores a common theme: targets are coming down, but conviction on direction is split. TD Cowen reinstated coverage at Hold with a $160 target on October 8. Citigroup trimmed its target to $160 from $172 the prior week while holding its Neutral rating. JP Morgan moved the other way, nudging its Overweight target up to $161 from $159 on October 2. Evercore ISI cut to $150 from $158 with an In-Line rating. With BNY at $142.72, the range of current analyst targets ($150 to $172 across active names) implies the stock is trading at a moderate discount to the cautious end of the Street's fair value range. The consensus sits at Hold, with eight holders of that rating and no analysts in the data showing an outright Sell.
The bull and bear cases are well-defined ahead of the print. Bulls point to $62.6 trillion in assets under custody or administration, record Q2 revenue of $5.7 billion, and 20% year-over-year NII growth. The bank's Piotroski F-score of 7 and a dividend factor rank in the 95th percentile of its universe reinforce the quality-income angle. Bears focus on capital compression: CET1 flat at 11.0% versus 11.5% a year ago, SLR slipping to 6.3%, and macro risks from elevated inflation and geopolitical uncertainty that could pressure AUM-linked fee income if markets deteriorate further. The price-to-book multiple has fallen roughly 0.32 turns over the past 30 days, now at 2.25x, compressing alongside the stock. The P/E of 14.2x is down more than two turns over the same window.
One signal worth flagging: Wikipedia and ORTEX page-view data show retail attention running at a z-score of 2.9 relative to BNY's own 90-day history, a notably elevated reading as of September 27. This is an attention metric, not a revenue indicator, but it does reflect the degree to which the stock has entered a broader conversation during its drawdown.
Institutional holders remain broadly stable. BlackRock added around 1.5 million shares to reach 8.5% of the float. FMR added roughly 2.8 million shares. Dodge & Cox, which disclosed a drop from 5.3% to 3.7% of class in a February 13G/A filing, has reduced its reported stake materially, though per standard 13D/G disclosure rules, positions are as-last-disclosed and holders dropping below the 5% threshold may exit without further filings. Insider activity this week consists almost entirely of routine director compensation grants at prices near $143.92, transaction code A, not open-market purchases, and a prior series of planned 10b5-1 sales by Senior Executive VP Jose Minaya at prices in the $148 to $163 range in late August and September. Neither cluster carries much signal about management's near-term outlook.
The last two BNY earnings prints produced positive 1-day moves of roughly 4.1% and 2.4%, suggesting the stock has historically rewarded the results day itself. With close peers STT down 0.2% on the week and NTRS off 0.7%, financials custody names have broadly tracked BNY lower. GS fell 1.5% over the same window, while MS managed a 0.9% gain, a divergence that reflects the different revenue mixes between trading-heavy and asset-servicing names heading into results season.
The Q3 print on October 15 will test whether the NII expansion and fee growth story that drove record Q2 revenues has held up through a quarter marked by market volatility and a weaker macro backdrop, and whether the capital ratios that concerned bears have stabilised or slipped further.
See the live data behind this article on ORTEX.
Open BNY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
